In vitro evidence for senescent multinucleated melanocytes as a source for tumor-initiating cells

Cell Death and Disease

Volumn 6, Issue 4, 2015, Pages

  Leikam, C ^a   Hufnagel, A L ^a   Otto, C ^b   Murphy, D J ^c   Muhling B ^b   Kneitz, S ^a   Nanda, I ^a   Schmid, M ^a   Wagner, T U ^a   Haferkamp, S ^d   Brocker E B ^b   Schartl, M ^a,b   Meierjohann, S ^a,b  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^c UNIVERSITY OF GLASGOW   (United Kingdom)

^d UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 CHLORO 4 IODOANILINO) N CYCLOPROPYLMETHOXY 3,4 DIFLUOROBENZAMIDE; 2 MORPHOLINO 8 PHENYLCHROMONE; BETA GALACTOSIDASE; DOXYCYCLINE; MELAN A; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PROTEIN P53; REACTIVE OXYGEN METABOLITE; TRANSCRIPTION FACTOR NANOG; GUANOSINE TRIPHOSPHATASE; MEMBRANE PROTEIN; NRAS PROTEIN, HUMAN;

ANIMAL CELL; ANOIKIS; ARTICLE; CELL DIFFERENTIATION; CELL GROWTH; CELL POPULATION; CELL PROLIFERATION; CELL SELF-RENEWAL; CELL SIZE; CHROMOSOME ABERRATION; CONTROLLED STUDY; CYTOKINESIS; DNA DAMAGE; EMBRYO DEVELOPMENT; FLOW CYTOMETRY; GENE CONTROL; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; MELANOCYTE; MELANOMA; MELANOMA CELL; METASTASIS; MOUSE; MULTINUCLEAR CELL; NON-TRANSFORMED CELL; NONHUMAN; ONCOGENE N RAS; PHENOTYPE; PIGMENT CELL; PIGMENTED NEVUS; PRIORITY JOURNAL; PROGENY; PROMOTER REGION; SENESCENCE; SIGNAL TRANSDUCTION; TUMOR INITIATING CELL; AMINO ACID SEQUENCE; ANIMAL; CANCER STEM CELL; CELL AGING; METABOLISM; MOLECULAR GENETICS; NEVUS; NUDE MOUSE; PATHOLOGY; PHYSIOLOGY; XENOGRAFT;

AMINO ACID SEQUENCE; ANIMALS; CELL AGING; CELL PROLIFERATION; GTP PHOSPHOHYDROLASES; HETEROGRAFTS; HUMANS; IN VITRO TECHNIQUES; MELANOCYTES; MEMBRANE PROTEINS; MICE; MICE, NUDE; MOLECULAR SEQUENCE DATA; NEOPLASTIC STEM CELLS; NEVUS; SIGNAL TRANSDUCTION;

EID: 84989822531     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2015.71     Document Type: Article

References (54)

1. Michaloglou C, Vredeveld LC, Soengas MS, Denoyelle C, Kuilman T, van der Horst CM et al. BRAFE600-associated senescence-like cell cycle arrest of human naevi. Nature 2005; 436: 720-724.
2. Bevona C, Goggins W, Quinn T, Fullerton J, Tsao H. Cutaneous melanomas associated with nevi. Arch Dermatol 2003; 139: 1620-1624 discussion 1624.
3. Guo X, Keyes WM, Papazoglu C, Zuber J, Li W, Lowe SW et al. TAp63 induces senescence and suppresses tumorigenesis in vivo. Nat Cell Biol 2009; 11: 1451-1457.
4. Swarbrick A, Roy E, Allen T, Bishop JM. Id1 cooperates with oncogenic Ras to induce metastatic mammary carcinoma by subversion of the cellular senescence response. Proc Natl Acad Sci USA 2008; 105: 5402-5407.
5. Braig M, Lee S, Loddenkemper C, Rudolph C, Peters AH, Schlegelberger B et al. Oncogene-induced senescence as an initial barrier in lymphoma development. Nature 2005; 436: 660-665.
6. Collado M, Gil J, Efeyan A, Guerra C, Schuhmacher AJ, Barradas M et al. Tumour biology: Senescence in premalignant tumours. Nature 2005; 436: 642.
7. DeNicola GM, Tuveson DA. RAS in cellular transformation and senescence. Eur J Cancer 2009; 45: 211-216.
8. Land H, Parada LF, Weinberg RA. Cellular oncogenes and multistep carcinogenesis. Science 1983; 222: 771-778.
9. Chen Z, Trotman LC, Shaffer D, Lin HK, Dotan ZA, Niki M et al. Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis. Nature 2005; 436: 725-730.
10. Aird KM, Zhang G, Li H, Tu Z, Bitler BG, Garipov A et al. Suppression of nucleotide metabolism underlies the establishment and maintenance of oncogene-induced senescence. Cell Rep 2013; 3: 1252-1265.
11. Leikam C, Hufnagel A, Schartl M, Meierjohann S. Oncogene activation in melanocytes links reactive oxygen to multinucleated phenotype and senescence. Oncogene 2008; 27: 7070-7082.
12. Haferkamp S, Scurr LL, Becker TM, Frausto M, Kefford RF, Rizos H. Oncogene-induced senescence does not require the p16(INK4a) or p14ARF melanoma tumor suppressors. J Invest Dermatol 2009; 129: 1983-1991.
13. Akakura S, Nochajski P, Gao L, Sotomayor P, Matsui S, Gelman IH. Rb-dependent cellular senescence, multinucleation and susceptibility to oncogenic transformation through PKC scaffolding by SSeCKS/AKAP12. Cell Cycle 2010; 9: 4656-4665.
14. Kuilman T, Michaloglou C, Mooi WJ, Peeper DS. The essence of senescence. Genes Dev 2010; 24: 2463-2479.
15. Cohen LM. The starburst giant cell is useful for distinguishing lentigo maligna from photodamaged skin. J Am Acad Dermatol 1996; 35: 962-968.
16. Bennett DC, Cooper PJ, Hart IR. A line of non-tumorigenic mouse melanocytes, syngeneic with the B16 melanoma and requiring a tumour promoter for growth. Int J Cancer 1987; 39: 414-418.
17. Levy C, Khaled M, Fisher DE. MITF: Master regulator of melanocyte development and melanoma oncogene. Trends Mol Med 2006; 12: 406-414.
18. Boiko AD, Razorenova OV, van de Rijn M, Swetter SM, Johnson DL, Ly DP et al. Human melanoma-initiating cells express neural crest nerve growth factor receptor CD271. Nature 2010; 466: 133-137.
19. Florenes VA, Holm R, Myklebost O, Lendahl U, Fodstad O. Expression of the neuroectodermal intermediate filament nestin in human melanomas. Cancer Res 1994; 54: 354-356.
20. Hotta A, Cheung AY, Farra N, Vijayaragavan K, Seguin CA, Draper JS et al. Isolation of human iPS cells using EOS lentiviral vectors to select for pluripotency. Nat Methods 2009; 6: 370-376.
21. Simpson AJ, Caballero OL, Jungbluth A, Chen YT, Old LJ. Cancer/testis antigens, gametogenesis and cancer. Nat Rev Cancer 2005; 5: 615-625.
22. Maclean G, Dolle P, Petkovich M. Genetic disruption of CYP26B1 severely affects development of neural crest derived head structures, but does not compromise hindbrain patterning. Dev Dyn 2009; 238: 732-745.
23. Grichnik JM. Melanoma, nevogenesis, and stem cell biology. J Invest Dermatol 2008; 128: 2365-2380.
24. Kumar SM, Liu S, Lu H, Zhang H, Zhang PJ, Gimotty PA et al. Acquired cancer stem cell phenotypes through Oct4-mediated dedifferentiation. Oncogene 2012; 31: 4898-4911.
25. Cheli Y, Giuliano S, Botton T, Rocchi S, Hofman V, Hofman P et al. Mitf is the key molecular switch between mouse or human melanoma initiating cells and their differentiated progeny. Oncogene 2011; 30: 2307-2318.
26. Carreira S, Goodall J, Denat L, Rodriguez M, Nuciforo P, Hoek KS et al. Mitf regulation of Dia1 controls melanoma proliferation and invasiveness. Genes Dev 2006; 20: 3426-3439.
27. Laisney JA, Braasch I, Walter RB, Meierjohann S, Schartl M. Lineage-specific co-evolution of the Egf receptor/ligand signaling system. BMC Evol Biol 2010; 10: 27.
28. Di Micco R, Fumagalli M, Cicalese A, Piccinin S, Gasparini P, Luise C et al. Oncogeneinduced senescence is a DNA damage response triggered by DNA hyper-replication. Nature 2006; 444: 638-642.
29. Meierjohann S. Oxidative stress in melanocyte senescence and melanoma transformation. Eur J Cell Biol 2014; 93: 36-41.
30. Schaafhausen MK, Yang WJ, Centanin L, Wittbrodt J, Bosserhoff A, Fischer A et al. Tumor angiogenesis is caused by single melanoma cells in a manner dependent on reactive oxygen species and NF-kappaB. J Cell Sci 2013; 126: 3862-3872.
31. Lokaj K, Meierjohann S, Schutz C, Teutschbein J, Schartl M, Sickmann A. Quantitative differential proteome analysis in an animal model for human melanoma. Journal of proteome research 2009; 8: 1818-1827.
32. Weyemi U, Lagente-Chevallier O, Boufraqech M, Prenois F, Courtin F, Caillou B et al. ROS-generating NADPH oxidase NOX4 is a critical mediator in oncogenic H-Ras-induced DNA damage and subsequent senescence. Oncogene 2012; 31: 1117-1129.
33. Shinohara M, Adachi Y, Mitsushita J, Kuwabara M, Nagasawa A, Harada S et al. Reactive oxygen generated by NADPH oxidase 1 (Nox1) contributes to cell invasion by regulating matrix metalloprotease-9 production and cell migration. J Biol Chem 2010; 285: 4481-4488.
34. Braumuller H, Wieder T, Brenner E, Assmann S, Hahn M, Alkhaled M et al. T-helper-1-cell cytokines drive cancer into senescence. Nature 2013; 494: 361-365.
35. Ohanna M, Giuliano S, Bonet C, Imbert V, Hofman V, Zangari J et al. Senescent cells develop a PARP-1 and nuclear factor-{kappa}B-associated secretome (PNAS). Genes Dev 2011; 25: 1245-1261.
36. Rodier F, Campisi J. Four faces of cellular senescence. J Cell Biol 2011; 192: 547-556.
37. Cruickshanks HA, McBryan T, Nelson DM, VanderKraats ND, Shah PP, van Tuyn J et al. Senescent cells harbour features of the cancer epigenome. Nat Cell Biol 2013; 15: 1495.
38. Evan GI, d'Adda di Fagagna F. Cellular senescence: Hot or what? Curr Opin Genet Dev 2009; 19: 25-31.
39. Vredeveld LC, Possik PA, Smit MA, Meissl K, Michaloglou C, Horlings HM et al. Abrogation of BRAFV600E-induced senescence by PI3K pathway activation contributes to melanomagenesis. Genes Dev 2012; 26: 1055-1069.
40. Purdue MP, From L, Kahn HJ, Armstrong BK, Kricker A, Gallagher RP et al. Etiologic factors associated with p53 immunostaining in cutaneousmalignant melanoma. Int J Cancer 2005; 117: 486-493.
41. Katz SK, Guitart J. Starburst giant cells in benign nevomelanocytic lesions. J Am Acad Dermatol 1998; 38: 283.
42. Pilch H, Gunzel S, Schaffer U, Tanner B, Heine M. Evaluation of DNA ploidy and degree of DNA abnormality in benign and malignant melanocytic lesions of the skin using video imaging. Cancer 2000; 88: 1370-1377.
43. Sagebiel RW. Melanocytic nevi in histologic association with primary cutaneous melanoma of superficial spreading and nodular types: Effect of tumor thickness. J Invest Dermatol 1993; 100: 322S-325S
44. Longo C, Rito C, Beretti F, Cesinaro AM, Pineiro-Maceira J, Seidenari S et al. De novo melanoma and melanoma arising from pre-existing nevus: In vivo morphologic differences as evaluated by confocal microscopy. J Am Acad Dermatol 2011; 65: 604-614.
45. Atillasoy ES, Seykora JT, Soballe PW, Elenitsas R, Nesbit M, Elder DE et al. UVB induces atypical melanocytic lesions and melanoma in human skin. Am J Pathol 1998; 152: 1179-1186.
46. Storchova Z, Kuffer C. The consequences of tetraploidy and aneuploidy. J Cell Sci 2008; 121: 3859-3866.
47. Sundaram M, Guernsey DL, Rajaraman MM, Rajaraman R. Neosis: A novel type of cell division in cancer. Cancer Biol Ther 2004; 3: 207-218.
48. Salmina K, Jankevics E, Huna A, Perminov D, Radovica I, Klymenko T et al. Up-regulation of the embryonic self-renewal network through reversible polyploidy in irradiated p53-mutant tumour cells. Exp Cell Res 2010; 316: 2099-2112.
49. Vitale I, Senovilla L, Jemaa M, Michaud M, Galluzzi L, Kepp O et al. Multipolar mitosis of tetraploid cells: Inhibition by p53 and dependency on Mos. Embo J 2010; 29: 1272-1284.
50. Erenpreisa J, Cragg MS. MOS, aneuploidy and the ploidy cycle of cancer cells. Oncogene 2010; 29: 5447-5451.
51. Zhang S, Mercado-Uribe I, Xing Z, Sun B, Kuang J, Liu J. Generation of cancer stem-like cells through the formation of polyploid giant cancer cells. Oncogene 2013; 33: 116-128.
52. Landsberg J, Kohlmeyer J, Renn M, Bald T, Rogava M, Cron M et al. Melanomas resist T-cell therapy through inflammation-induced reversible dedifferentiation. Nature 2012; 490: 412-416.
53. Leikam C, Hufnagel A, Walz S, Kneitz S, Fekete A, Muller MJ et al. Cystathionase mediates senescence evasion in melanocytes and melanoma cells. Oncogene 2014; 33: 771-782.
54. Murphy DJ, Junttila MR, Pouyet L, Karnezis A, Shchors K, Bui DA et al. Distinct thresholds govern Myc's biological output in vivo. Cancer Cell 2008; 14: 447-457.